recent
advanc
understand
differ
rna
uniqu
featur
biolog
reveal
wealth
inform
howev
approach
identifi
small
molecul
target
newli
discov
biolog
regulatori
element
lack
applic
new
biochem
screen
designbas
technolog
coupl
resurg
interest
phenotyp
screen
result
sever
compel
success
target
rna
number
recent
advanc
suggest
achiev
longstand
goal
develop
druglik
biolog
activ
small
molecul
target
rna
fact
possibl
review
highlight
advanc
success
approach
target
rna
divers
small
molecul
potenti
technolog
pave
way
new
type
rnatarget
therapeut
rna
transcript
emerg
key
regul
divers
biolog
phenomena
classic
rna
view
carrier
genet
inform
exist
sole
transmit
messag
protein
code
guid
process
protein
biosynthesi
modern
view
encompass
expand
role
rna
divers
rang
rna
molecul
understood
broad
farreach
role
modul
gene
express
biolog
process
variou
mechan
breaker
joyc
one
recent
report
estim
human
genom
transcrib
rna
transcript
code
protein
indic
vast
major
rna
noncod
hangauer
et
al
furthermor
larg
number
newli
discov
noncod
rna
diseas
associ
cancer
well
nontumorigen
diseas
cheetham
et
al
estel
thu
realiz
rna
contribut
diseas
state
apart
code
pathogen
protein
like
provid
wealth
previous
unrecogn
therapeut
target
cooper
et
al
given
mani
rna
adopt
discret
secondari
tertiari
structur
pivot
role
biolog
attract
target
small
molecul
mammal
biolog
function
rna
highli
divers
act
mani
level
regul
rna
vari
greatli
sequenc
length
rang
small
hairpin
consist
nucleotid
long
noncod
rna
consist
sever
thousand
nucleotid
one
exampl
small
rna
molecul
microrna
mir
approxim
nucleotid
sequenc
produc
dicer
process
rna
hairpin
function
suppress
gene
express
via
inhibit
degrad
messeng
rna
mrna
anoth
exampl
noncod
rna
telomer
repeat
rna
terra
consist
oligomer
sequenc
polymorph
rna
gquadruplex
believ
requir
proper
telomer
function
ripp
luke
oligonucleotid
repeat
expans
diseas
seri
patholog
occur
oligomer
expans
rna
result
diseas
state
cag
n
huntington
diseas
galkamarciniak
et
al
gggccc
n
amyotroph
later
sclerosi
al
dejesushernandez
et
al
larger
long
noncod
rna
lncrna
hotair
mani
other
contribut
oncogenesi
direct
bind
sequestr
variou
tumor
suppressor
protein
though
mechan
alway
clear
cheetham
et
al
new
famili
function
noncod
rna
continu
discov
includ
pirna
snrna
snorna
other
estel
addit
canon
noncod
rna
sequenc
altern
splice
mrna
provid
multipl
gene
product
transcrib
rna
sequenc
misregul
process
often
diseaseassoci
scotti
swanson
posttranscript
modif
methyl
also
discov
modul
rna
structur
function
well
chen
et
al
helm
alfonzo
li
mason
apart
mammalian
system
rna
play
pivot
role
virus
bacteria
orthogon
homolog
function
element
viral
bacteri
transcriptom
genom
mammalian
transcriptom
make
rna
structur
excel
target
antiinfect
drug
concept
gain
signific
attent
histor
genom
retrovirus
hiv
shown
contain
noncod
cisact
function
element
transactiv
respons
tar
hairpin
frameshift
signal
fss
rev
respons
element
rre
le
grice
rna
multifunct
role
regul
polymeras
activ
viral
infect
progress
multipl
level
studi
drug
target
similarli
viral
rna
intern
ribosom
entri
site
ire
enabl
capindepend
translat
studi
therapeut
relev
target
polioviru
hcv
davi
seth
bacteria
also
contain
natur
occur
rna
aptam
call
riboswitch
bind
secondari
metabolit
regul
gene
express
bacteria
recent
work
demonstr
riboswitch
uniqu
bacteria
rna
emerg
major
area
studi
rna
biolog
rang
serv
model
system
studi
rna
structur
potenti
drug
target
breaker
joyc
addit
new
function
develop
modern
analyt
techniqu
usher
explos
knowledg
rna
structur
earli
view
tend
consid
rna
highli
flexibl
molecul
larg
devoid
discret
structur
howev
current
view
consid
rna
exist
dynam
ensembl
structur
conform
includ
welldefin
secondari
tertiari
fold
salmon
et
al
tradit
xray
crystallographi
nuclear
magnet
reson
nmr
spectroscopi
two
techniqu
use
character
atom
resolut
rna
structur
although
without
technic
challeng
method
yield
profound
insight
high
resolut
structur
rna
molecul
rang
size
structur
featur
cryoelectron
microscopi
cryoem
recent
undergon
revolut
resolut
achiev
compet
xray
crystallographi
term
structur
analysi
increasingli
larg
rna
structur
garmann
et
al
hand
advanc
nmr
spectroscopi
comput
model
critic
develop
view
rna
dynam
system
stelzer
et
al
anoth
complementari
biophys
techniqu
small
angl
xray
scatter
sax
also
emerg
power
way
analyz
fold
adopt
particular
rna
solut
offer
view
global
shape
fang
et
al
chemic
probe
techniqu
select
acyl
analyz
primer
extens
shape
proven
highli
use
evalu
rna
structur
singl
nucleotid
resolut
entir
viral
genom
may
structur
analyz
singl
experi
watt
et
al
frontier
area
applic
probe
techniqu
rna
structur
vivo
goal
confirm
biolog
relev
conform
rna
spital
et
al
despit
develop
power
techniqu
analysi
rna
structur
discoveri
new
function
abil
identifi
design
inhibitor
bind
perturb
function
rna
lag
far
behind
date
commonli
employ
method
target
diseaseassoci
rna
base
use
antisens
technolog
sirna
antisens
technolog
highli
effect
small
number
drug
use
approach
approv
mcclorey
wood
howev
approach
primarili
reli
derivat
oligonucleotid
structur
suffer
poor
cell
permeabl
distribut
due
requisit
anion
charact
limit
applic
therapeut
small
molecul
howev
often
offer
advantag
desir
properti
good
absorpt
distribut
oral
bioavail
addit
small
molecul
potenti
recogn
rna
virtu
secondari
tertiari
structur
oppos
sequenc
thu
small
molecul
provid
orthogon
mean
target
differ
rna
structur
element
bulg
loop
junction
pseudoknot
higher
order
structur
virtu
recogn
bind
uniqu
fold
rather
complementari
sequenc
earli
approach
identifi
rnabind
molecul
led
discoveri
aminoglycosid
potent
clinic
use
molecul
bind
rna
electrostat
interact
best
modest
select
system
toxic
howev
recent
approach
favor
develop
druglik
rnabind
compound
display
improv
physiochem
properti
welldefin
pattern
select
purpos
review
use
term
druglik
refer
compound
predict
demonstr
good
medicin
chemistri
properti
potenc
solubl
select
distribut
rare
case
oral
bioavail
compound
usual
tend
molecular
weight
fewer
hydrogen
bond
donor
acceptor
low
polar
surfac
area
reactivepromiscu
scaffold
desir
featur
compound
interact
rna
intercal
sequenc
electrostat
complementar
mean
specif
molecular
recognit
event
uniqu
particular
rna
target
new
techniqu
increasingli
requir
defin
rule
identifi
design
studi
rnabind
small
molecul
advanc
molecul
biolog
probe
potenti
therapeut
howev
overcom
challeng
highli
anion
natur
rna
compound
flexibl
dynam
structur
remain
main
roadblock
develop
small
molecul
inhibitor
moreov
mani
put
small
molecul
bind
site
rna
much
polar
solvent
expos
bind
site
protein
complic
ligand
design
effort
despit
challeng
number
promis
result
report
recent
suggest
long
soughtaft
goal
develop
small
molecul
drug
target
rna
may
inde
achiev
review
discuss
recent
develop
technolog
approach
use
identifi
inhibitor
focu
mostli
advanc
report
sinc
sever
comprehens
review
guan
disney
le
grice
thoma
hergenroth
exclud
ribosomebind
molecul
molecul
well
review
elsewher
arenz
wilson
hermann
poehlsgaard
douthwait
flexibl
dynam
natur
rna
structur
repres
one
challeng
associ
target
rna
small
molecul
howev
abil
identifi
small
molecul
bind
specif
rna
target
structurebas
approach
take
dynam
account
provid
viabl
avenu
identifi
potent
binder
shortridg
varani
recent
exampl
alhashimi
laboratori
success
use
nmr
residu
dipolar
coupl
rdc
data
calcul
dynam
ensembl
transactiv
respons
element
tar
rna
promin
target
inhibit
hiv
replic
le
grice
dynam
ensembl
use
start
point
virtual
screen
identifi
small
molecul
target
entir
structur
landscap
tar
stelzer
et
al
small
molecul
librari
screen
conform
tar
ensembl
identifi
six
small
molecul
includ
netilmicin
n
n
dimethylamilorid
figur
bind
tar
high
affin
k
nm
inhibit
interact
tat
peptid
vitro
k
valu
rang
nm
sever
identifi
compound
show
signific
deterior
bind
affin
measur
presenc
excess
trna
indic
nonspecif
trna
bind
howev
chang
k
valu
observ
netilmicin
found
select
bind
tar
rna
resembl
tar
hairpin
includ
tar
variant
neglig
affin
prokaryot
ribosom
asit
hairpin
fold
weaker
affin
rre
hairpin
fold
weaker
affin
addit
netilmicin
bound
tar
mutant
delet
singl
cytosin
bulg
residu
fold
weaker
affin
wildtyp
tar
netilmicin
also
show
uniqu
interact
involv
bulg
upper
stem
apic
loop
tar
determin
nmr
chemic
shift
map
experi
addit
netilmicin
specif
inhibit
tatmedi
activ
promot
cell
line
inhibit
replic
indic
cell
line
tzmbl
isol
ic
valu
taken
togeth
discoveri
netilmicin
potent
binder
tar
demonstr
abil
use
nmrinform
comput
dynam
ensembl
suitabl
foundat
identifi
rnatarget
small
molecul
anoth
rna
viru
ire
hcv
bind
host
cell
ribosom
subunit
initi
viral
translat
capindepend
fashion
adopt
order
structur
domin
independ
fold
rna
domain
parson
et
al
hermann
laboratori
report
threedimension
structur
ire
subdomain
iia
determin
xray
crystallographi
show
adopt
overal
bent
architectur
lshape
conform
stabil
three
dival
metal
ion
dibrov
et
al
importantli
determin
lshape
conform
agreement
previous
report
nmr
studi
full
domain
ii
lukavski
et
al
cryoem
investig
complex
boehring
et
al
spahn
et
al
like
maintain
architectur
subdomain
iia
critic
correct
bind
viral
mrna
ribosom
highthroughput
screen
librari
oligonucleotid
repres
ire
subdomain
iia
use
mass
spectrometrybas
screen
method
identifi
benzimidazol
contain
compound
k
ire
iia
model
seth
et
al
subsequ
new
class
benzimidazol
contain
compound
develop
extens
structureact
relationship
studi
sever
analog
identifi
submicromolar
affin
figur
use
inform
gather
crystallographi
hermann
cowork
develop
sever
fluorescencebas
assay
assess
bind
benzimidazolebas
ligand
rna
parson
et
al
fretbas
assay
monitor
interhel
angl
stem
flank
intern
loop
iia
via
measur
distanc
stem
termini
develop
use
determin
abil
benzimidazol
bind
oligonucleotid
mimic
ire
iia
addit
benzimidazol
result
dosedepend
quench
fret
ec
valu
mm
mg
unchang
presenc
excess
competitor
trna
data
suggest
benzimidazol
act
hcv
translat
inhibitor
induc
conform
widen
interhel
angl
ire
subdomain
iia
rna
addit
impact
hcv
translat
assess
human
cell
express
report
control
hcv
ire
compound
success
inhibit
iresdriven
translat
low
micromolar
concentr
xray
crystallograph
analysi
subdomain
iia
complex
benzimidazol
ligand
figur
verifi
widen
interhel
angl
dibrov
et
al
initi
benzimidazol
ligand
explor
subsequ
round
synthesi
ration
design
ligand
base
cocryst
structur
iia
rna
complex
ligand
ding
et
al
rynearson
et
al
recent
cryoem
studi
indic
domain
iia
adopt
bent
conform
complex
subunit
quad
et
al
yamamoto
et
al
therefor
linear
ligandbound
iia
domain
structur
identifi
crystallographi
may
prevent
conform
necessari
interact
yamamoto
et
al
addit
screen
subdomain
iia
rna
modular
ligand
contain
heterocycl
reveal
namido
substitut
acid
conjug
bind
subdomain
iia
micromolar
affin
arrest
rna
bent
state
interhel
angl
solut
carnevali
et
al
adapt
previous
mention
structurebas
fret
assay
monitor
interhel
angl
iia
rna
highthroughput
screen
format
also
led
identif
addit
iia
rnabind
compound
zhou
et
al
ration
design
approach
similarli
extend
develop
small
molecul
bind
r
cug
exp
rna
associ
myoton
dystrophi
type
multisystem
disord
affect
skelet
smooth
muscl
well
eye
heart
endocrin
system
central
nervou
system
caus
symptom
includ
myotonia
wast
muscl
cardiac
defect
r
cug
exp
locat
region
dystrophia
myotonica
protein
kinas
dmpk
mrna
caus
diseas
gainoffunct
mechan
rna
bind
sequest
protein
involv
rna
biogenesi
mbnl
muscleblindlik
famili
splice
regul
base
part
previous
develop
ligand
frameshift
site
rna
stemloop
xray
crystal
structur
r
cug
zimmerman
group
design
rnagroov
bind
inhibitor
r
cug
exp
compris
two
triaminotriazin
unit
connect
bisamidinium
linker
figur
triaminotriazin
unit
select
propens
form
base
triplet
uu
mismatch
known
januswedg
unit
bisamidinium
moieti
suggest
groovebind
scaffold
cug
recognit
compound
exhibit
low
micromolar
affin
k
r
cug
itc
show
select
bind
target
includ
trna
gsttag
hiv
frameshift
site
rna
r
ccug
capabl
disrupt
cug
interact
vitro
appar
k
determin
electrophoret
mobil
shift
assay
emsa
compound
show
good
cell
permeabl
vitro
reduc
cug
exp
ribonuclear
foci
format
cell
cultur
model
partial
restor
misregul
splice
two
premrna
cardiac
troponin
ctnt
insulin
receptor
ir
vivo
compound
suppress
phenotyp
associ
r
cug
exp
rnainduc
toxic
transgen
drosophila
model
ligand
use
foundat
ration
design
multitarget
agent
bind
ctg
exp
dna
inhibit
format
r
cug
exp
transcript
bind
r
cug
exp
inhibit
sequestr
cleav
r
cug
exp
rnaselik
manner
nguyen
et
al
work
stand
particularli
notabl
rel
rare
use
ration
design
rnabind
small
molecul
valid
activ
anim
model
addit
work
group
report
sever
r
cug
exp
bind
compound
exampl
disney
group
report
substitut
naphthyridin
figur
identifi
highthroughput
screen
shown
inhibit
r
cug
exp
interact
ic
use
fretbas
assay
chen
et
al
childsdisney
et
al
naphthyridin
bind
r
cug
k
nm
interact
uu
loop
r
cug
exp
displac
cell
model
improv
premrna
splice
defect
specif
splice
event
caus
reduct
nuclear
foci
format
compound
also
subsequ
identifi
disney
lab
inhibitor
see
haga
et
al
disney
lab
also
report
benzimidazol
figur
identifi
screen
rnafocus
small
molecul
librari
oligomer
hoescht
dyelik
compound
bind
r
cug
exp
cell
promis
effect
associ
defect
cell
model
childsdisney
et
al
pushechnikov
et
al
rzuczek
et
al
anoth
designbas
approach
recognit
specif
rna
structur
come
chenoweth
group
recent
report
sever
paper
describ
use
triptycenebas
molecular
scaffold
recogn
rna
junction
three
way
junction
ubiquit
throughout
transcriptom
howev
small
molecul
recogn
known
chenoweth
group
initi
report
simpl
triptycen
function
cation
group
bound
dna
rna
threeway
junction
demonstr
compound
exhibit
cell
permeabl
well
cytotox
chenoweth
work
show
divers
triptycen
molecul
synthes
modular
effici
fashion
includ
solid
phase
method
like
use
prepar
librari
triptycen
go
forward
potenti
specif
junction
recognit
barro
et
al
yoon
et
al
final
recent
report
demonstr
function
triptycen
figur
also
use
modul
e
coli
rpoh
rna
temperatur
sensor
indic
util
recogn
rna
structur
bacteria
well
barro
et
al
date
work
area
focus
molecular
recognit
develop
synthet
method
access
new
triptycen
scaffold
howev
clear
approach
potenti
broad
applic
rna
recognit
target
futur
effort
anoth
structurebas
approach
park
cowork
perform
silico
screen
discov
compound
target
frameshift
signal
pseudoknot
sever
acut
respiratori
syndrom
coronaviru
sarscov
park
et
al
sarscov
util
essenti
program
ribosom
frameshift
rf
synthes
key
replic
compon
stabil
structur
rna
pseudoknot
present
rf
site
essenti
effici
frameshift
viral
replic
indic
may
valuabl
target
small
molecul
author
use
structur
model
sarspseudoknot
perform
virtual
ligand
screen
dock
approxim
compound
commerci
avail
chemic
databas
leadquest
produc
set
highrank
compound
hit
valid
perform
use
pseudoknotdriven
dual
luciferas
report
assay
biochem
cellbas
assay
novel
ligand
inhibit
rf
sarscov
identifi
dramat
decreas
rf
vitro
inhibit
rf
effici
hek
cell
ic
approxim
figur
select
evalu
use
similar
report
assay
pseudoknot
pea
enat
mosaic
viru
compound
activ
later
report
woodsid
bind
studi
spr
reveal
appar
k
ritchi
et
al
remain
unclear
compound
k
could
potent
cellular
effect
final
analysi
use
optic
tweezer
reveal
ligand
bind
appear
influenc
ensembl
conform
popul
rna
rather
influenc
mechan
stabil
base
studi
author
propos
mechan
wherebi
ligand
reduc
rf
effici
decreas
conform
plastic
sarspseudoknot
ritchi
et
al
addit
design
ligand
de
novo
basi
rna
structur
relat
strategi
redesign
cognat
ligand
particular
rna
primarili
applic
riboswitch
natur
occur
aptam
regul
gene
express
chang
conform
presenc
metabolit
small
molecul
ligand
last
decad
sever
group
use
structureguid
ration
design
identifi
optim
small
molecul
bind
select
riboswitch
aptam
base
structur
cognat
ligand
includ
small
molecul
target
cdigmp
furukawa
et
al
glm
luns
et
al
purin
gilbert
et
al
lysin
blount
et
al
riboswitch
case
synthet
natur
analog
cognat
ligand
also
demonstr
potent
antibacteri
activ
suggest
potenti
develop
riboswitchtarget
antibiot
blount
et
al
kim
et
al
lee
et
al
mansjo
johansson
ott
et
al
recent
analog
riboflavin
design
via
medicin
chemistri
optim
bind
riboswitch
recogn
natur
coenzym
flavin
mononucleotid
fmn
regul
homeostasi
fmn
riboflavin
report
breaker
lab
collabor
sever
industri
group
blount
et
al
vitro
bind
trigger
function
fmn
riboswitch
show
antibacteri
activ
c
difficil
prevent
antibioticinduc
c
difficil
infect
cdi
mice
nearli
effect
fidaxomicin
current
cdi
treatment
clear
mani
case
substanti
inform
structur
dynam
given
rna
avail
inform
may
leverag
design
small
molecul
binder
good
affin
biolog
activ
anoth
power
tool
success
use
design
small
molecul
bind
rna
target
informaticsdriven
ration
design
approach
term
inforna
develop
disney
laboratori
inforna
util
databas
experiment
determin
rna
motifsmal
molecul
interact
identifi
selectionbas
strategi
call
twodimension
combinatori
screen
structureact
relationship
sequenc
start
disney
et
al
briefli
small
molecul
librari
conjug
agaros
microarray
surfac
probe
bind
librari
small
rna
motif
includ
hairpin
loop
bulg
like
found
compon
larger
cellular
rna
quantif
specif
bound
rna
accomplish
excis
individu
spot
array
sequenc
correspond
bound
oligonucleotid
next
start
use
score
rna
motifsmal
molecul
interact
velagapudi
et
al
inforna
use
identifi
lead
compound
rna
interest
compar
structur
motif
present
target
rna
motif
databas
annot
rna
motifsmal
molecul
interact
deriv
given
rna
interest
inforna
softwar
provid
target
structur
motif
input
rna
correspond
lead
small
molecul
hit
fit
predict
rnasmal
molecul
interact
determin
start
analysi
velagapudi
et
al
power
demonstr
abil
inforna
discoveri
compound
bind
microrna
inhibit
biogenesi
select
similar
antagomir
velagapudi
et
al
discov
small
molecul
inhibit
drosha
process
lead
upregul
target
induct
apoptosi
breast
cancer
cell
recent
disney
laboratori
success
employ
inforna
identifi
small
molecul
ligand
sever
diseaseassoci
rna
structur
well
one
promin
exampl
repeat
expans
r
ggggcc
exp
common
genet
caus
frontotempor
dementia
amyotroph
later
sclerosi
su
et
al
repeat
expans
rna
form
nuclear
foci
sequest
variou
rnabind
protein
caus
toxic
undergo
repeatassoci
nonatg
ran
translat
produc
protein
form
neuron
inclus
throughout
central
nervou
system
base
determin
mix
hairpingquadruplex
structur
r
ggggcc
exp
lead
small
molecul
bind
rna
identifi
use
inforna
figur
hit
compound
experiment
screen
use
biochem
displac
assay
three
lead
compound
identifi
valid
kinet
bind
studi
r
ggggcc
reveal
k
compound
respect
figur
compound
show
similar
bind
affin
r
cgg
r
ggcc
possess
gg
intern
loop
structur
similar
r
ggggcc
howev
compound
significantli
decreas
bind
affin
hairpin
fulli
pair
stem
demonstr
modest
select
gg
intern
loop
compound
success
engag
r
ggggcc
rna
cell
demonstr
competit
chemclip
valid
bind
cellulo
cell
express
r
ggggcc
result
synthesi
poli
gp
poli
ga
protein
ran
translat
treatment
two
lead
compound
significantli
decreas
poli
gp
poli
ga
protein
level
demonstr
abil
small
molecul
inhibit
ran
translat
compound
also
capabl
inhibit
nuclear
foci
format
determin
rna
fish
addit
compound
inhibit
ran
translat
foci
format
ineuron
r
ggggcc
expans
suggest
potenti
small
molecul
inhibitor
r
ggggcc
exp
lead
structur
therapeut
develop
treatment
similarli
disney
finney
laboratori
use
inforna
identifi
small
molecul
bind
microrna
silenc
mammalian
target
rapamycin
mtor
mean
interrog
role
tumor
cell
growth
hypox
condit
haga
et
al
precursor
hairpin
structur
pars
composit
motif
nucleotid
uu
intern
loop
present
dicer
drosha
process
site
screen
inforna
figur
identifi
compound
screen
test
abil
modul
biogenesi
five
potenti
lead
compound
identifi
potent
compound
figur
success
disrupt
inhibit
valid
target
demonstr
fluorescencebas
report
assay
cellulo
caus
accumul
decreas
matur
level
qrtpcr
compound
select
bound
rna
contain
nucleotid
uu
intern
loop
dicer
drosha
site
control
rna
contain
ua
pair
bind
constant
midnanomolar
rang
show
bind
dna
control
gel
shift
assay
impress
microarray
analysi
cell
treat
reveal
chang
mrna
mirna
express
similar
cell
transfect
antagomir
indic
compound
select
oligonucleotid
base
antisens
inhibitor
howev
disney
lab
also
report
bind
r
cug
exp
rna
well
see
discuss
chen
et
al
childsdisney
et
al
immunodefici
mice
implant
cell
pretreat
well
postimplant
intraperiton
ip
inject
imped
tumor
growth
compar
untreat
cell
qrtpcr
analysi
develop
tumor
reveal
decreas
level
atm
increas
level
mtor
taken
togeth
work
stand
power
exampl
inforna
platform
abil
identifi
highli
select
rnabind
small
molecul
modul
mirna
biogenesi
vivo
combin
r
ggggcc
exp
exampl
primarili
focus
precursor
mirna
inhibitor
haga
et
al
luo
disney
velagapudi
et
al
clear
inforna
matur
highli
use
tool
discoveri
rnabind
molecul
fragmentbas
drug
discoveri
fbdd
modern
method
develop
highli
potent
inhibitor
desir
druglik
properti
briefli
method
employ
sensit
biophys
techniqu
identifi
low
molecular
weight
compound
weak
specif
interact
biomolecul
interest
identifi
compound
may
elabor
via
multipl
strategi
potent
select
inhibitor
method
enjoy
much
success
develop
enzym
inhibitor
recent
begun
use
broadli
arena
rnabind
small
molecul
davidson
et
al
exampl
cressina
et
al
report
fragmentbas
approach
identifi
novel
thiamin
pyrophosph
tpp
riboswitch
ligand
cressina
et
al
tpp
riboswitch
locat
variou
bacteri
mrna
regul
express
thimd
operon
chang
conform
presenc
tpp
studi
librari
structur
chemic
divers
fragment
rule
three
compliant
mw
da
c
log
p
three
hydrogen
bond
donor
acceptor
puriti
mm
aqueou
solubl
screen
equilibrium
dialysi
h
thiamin
fragment
place
separ
chamber
riboswitch
allow
equilibr
concentr
radiolabel
ligand
measur
identifi
fragment
disrupt
thiaminerna
interact
screen
hit
initi
identifi
valid
nmr
select
hit
also
assess
use
equilibrium
dialysi
structur
differ
lysin
riboswitch
present
bacillu
subtili
lysc
sever
compound
figur
later
investig
week
laboratori
indepth
biophys
studi
order
provid
insight
mechan
bind
fragment
warner
et
al
cocryst
structur
e
coli
thim
tpp
riboswitch
fragment
reveal
fragment
occupi
bind
site
aminopyridin
tpp
howev
bind
fragment
result
rearrang
unoccupi
site
figur
addit
studi
via
sax
shape
show
complet
fold
achiev
tpp
bound
partial
fold
fragment
bound
taken
togeth
result
suggest
small
molecul
fragment
competit
tpp
may
stabil
differ
fold
pathway
fbdd
strategi
also
implement
identifi
novel
chemic
divers
fragment
bind
terra
camposoliva
laboratori
garavi
et
al
r
uuaggg
n
sequenc
fold
gquadruplex
requir
telomer
heterochromatin
format
cancer
cell
therefor
attract
anticanc
target
librari
fluorin
fragment
compound
screen
rna
contain
r
uuaggg
repeat
terra
use
f
nmr
spectroscopi
figur
spectra
fragment
collect
presenc
absenc
terra
compar
identifi
perturb
peak
intens
width
upon
addit
rna
target
molecul
identifi
initi
screen
compound
valid
repres
hit
shown
figur
six
compound
shown
interact
shorter
terra
construct
repeat
terra
four
compound
demonstr
select
terra
duplex
dna
phenylalanin
trna
hand
fnmr
respect
compound
interact
dna
analogu
terra
compound
shown
favor
parallel
conform
predomin
conform
rna
gquadruplex
present
terra
context
viral
rna
cowork
report
success
screen
fragment
inhibit
hiv
tattar
interact
use
fret
displac
assay
zeiger
et
al
valid
fragment
bind
tar
rna
use
h
nmr
h
noesi
experi
identifi
sever
hit
affin
rang
tattar
wellstudi
target
new
viral
rna
evalu
fragmentbas
approach
well
power
exampl
studi
genom
element
influenza
viru
influenza
viral
genom
contain
promot
region
highli
conserv
sequenc
locat
termini
fold
partial
duplex
bind
rnadepend
rna
polymeras
rdrp
promot
region
consid
attract
drug
target
previou
studi
demonstr
neomycin
bind
submicromolar
affin
kim
et
al
subsequ
varani
choi
group
report
fragmentbas
screen
small
molecul
bind
influenza
viru
promot
lee
et
al
librari
fragment
evalu
rnaobserv
h
nmr
screen
dpq
identifi
studi
inhibitor
figur
bind
mode
dpq
investig
nmr
structur
reveal
compound
bind
promot
major
groov
intern
loop
inhibit
may
occur
due
structur
chang
prevent
bend
helix
associ
rdrp
subunit
subsequ
work
focus
sar
studi
dpq
order
improv
cellular
activ
influenza
bottini
et
al
dpq
affin
hairpin
ic
influenza
sinc
piperazinyl
secondari
amin
involv
signific
contact
figur
analogu
modif
group
prepar
compound
display
improv
antivir
ic
maintain
k
valu
compar
dpq
although
fragmentbas
approach
yet
yield
select
highaffin
rna
binder
probabl
approach
play
larg
role
assess
druggabl
newli
discov
rna
structur
go
forward
thu
valu
fragmentbas
approach
may
develop
lead
specif
rna
structur
also
help
decid
rna
structur
druggabl
small
molecul
microarray
smm
approach
origin
develop
schreiber
discoveri
ligand
undrugg
protein
transcript
factor
wide
appli
field
bradner
et
al
bradner
et
al
hergenroth
et
al
hong
et
al
kawasumi
et
al
koehler
et
al
briefli
techniqu
small
molecul
spatial
array
robot
microarray
coval
link
glass
surfac
next
array
incub
fluoresc
label
biomolecul
array
imag
use
fluoresc
scanner
fluoresc
intens
quantifi
spot
array
statist
analysi
reveal
spot
larg
increas
fluoresc
upon
incub
correspond
discret
molecular
interact
oligonucleotid
associ
small
molecul
laboratori
advanc
use
smm
platform
identif
small
molecul
bind
structur
nucleic
acid
build
origin
work
employ
aminoglycosid
figur
bryan
wong
disney
et
al
first
assembl
librari
druglik
compound
contain
amin
alcohol
group
coval
react
array
librari
screen
less
day
littl
optim
one
exampl
abl
identifi
small
molecul
bind
hiv
tar
hairpin
sztubasolinska
et
al
fluoresc
label
tar
hairpin
screen
librari
smm
platform
three
compound
identifi
bound
tar
oligonucleotid
includ
hairpin
three
distinct
dna
sequenc
one
compound
bound
revers
tar
hairpin
k
figur
shape
profil
use
probe
compound
bind
context
entir
hiv
utr
ligand
bind
could
map
specif
tar
hairpin
structur
element
figur
thu
microarray
use
identifi
potent
noncation
compound
bind
select
rna
structur
even
simpl
hairpin
context
complex
structur
utr
recent
studi
use
smm
platform
identifi
molecul
select
bind
dna
gquadruplex
respons
control
express
myc
oncogen
disregul
mani
cancer
felsenstein
et
al
given
preval
quadruplex
promot
region
oncogen
ohnmacht
neidl
mrna
highli
like
smm
use
technolog
identifi
select
inhibitor
rna
quadruplex
well
power
method
evolutiondriven
small
molecul
discoveri
call
dynam
combinatori
chemistri
dcc
use
dcc
small
molecul
fragment
undergo
recombin
presenc
target
interest
produc
substanti
chemic
divers
therebi
allow
select
amplif
highest
affin
binder
equilibrium
shift
resinbound
dcc
rbdcc
approach
use
miller
laboratori
screen
librari
compound
small
molecul
bind
r
cug
exp
involv
gareiss
et
al
librari
creat
resinbound
cysteinecontain
peptid
ident
set
solutionphas
peptid
format
disulfid
bond
resinbound
solutionphas
cystein
provid
combinatori
librari
figur
librari
screen
fluoresc
label
r
cug
four
compound
identifi
low
micromolar
bind
affin
r
cug
compound
inhibit
cug
bind
interact
k
rang
enzym
fragment
complement
assay
secondgener
binder
figur
show
enhanc
select
spr
demonstr
signific
prefer
cug
ccug
rna
prefer
versu
cag
measur
bind
duplex
cugcag
sequenc
reduct
bind
fss
rna
improv
compound
block
translat
defect
cell
cultur
model
importantli
two
compound
success
improv
altern
premrna
splice
defect
mous
model
suggest
therapeut
applic
small
molecul
target
r
cug
exp
ofori
et
al
rbdcc
appli
miller
lab
discoveri
compound
bind
rna
target
regul
frameshift
hiv
precis
control
crucial
viral
prolifer
mcnaughton
et
al
product
essenti
gagpol
polyprotein
hiv
requir
nucleotid
ribosom
frameshift
part
direct
highli
conserv
downstream
rna
stemloop
rbdcc
librari
member
use
identifi
set
disulfidecontain
peptid
bind
fss
rna
figur
lead
compound
affin
fss
determin
spr
solut
phase
k
fluoresc
titrat
mcnaughton
et
al
furthermor
presenc
either
excess
competitor
yeast
trna
total
yeast
rna
effect
bind
affin
indic
good
select
pald
et
al
satur
bind
observ
dna
homologu
fss
unrel
rna
hairpin
singl
multipl
mutat
loop
region
fss
caus
reduct
bind
respect
optim
produc
olefin
bioisoster
enhanc
biostabl
compar
affin
pald
et
al
addit
sar
effort
produc
highaffin
binder
alter
frameshift
hek
cell
strongli
inhibit
viral
infect
pseudotyp
hiv
assay
ofori
et
al
seri
nmethyl
deriv
also
bind
fss
rna
low
nanomolar
affin
high
select
compound
readili
penetr
cell
membran
inhibit
infect
pseudotyp
hiv
assay
correl
compound
induc
chang
express
gagpol
polyprotein
hilimir
et
al
two
target
demonstr
rbdcc
power
approach
identifi
potent
select
biolog
activ
rnabind
small
molecul
leverag
power
select
approach
addit
biochem
biophys
approach
discuss
phenotyp
assay
also
shown
great
promis
discoveri
biolog
activ
rnabind
small
molecul
approach
use
phenotyp
readout
report
gene
assay
report
activ
particular
rna
rnaassoci
pathway
intact
cell
exampl
deiter
laboratori
demonstr
use
report
gene
assay
identifi
compound
act
specif
microrna
includ
gumireddi
et
al
naro
et
al
young
et
al
howev
clear
whether
compound
bind
directli
microrna
anoth
intracellular
target
anoth
promin
exampl
phenotyp
screen
come
studi
spinal
muscular
atrophi
sma
lifethreaten
motor
neuron
diseas
caus
defici
surviv
motor
neuron
smn
protein
palacino
et
al
sma
cell
lack
fulli
function
smn
protein
consequ
homozyg
delet
gene
gene
produc
smn
protein
although
gene
abl
partial
compens
low
level
smn
protein
singl
nucleotid
connelli
et
al
page
cell
chem
biol
author
manuscript
avail
pmc
septemb
transit
result
exclus
exon
ultim
decreas
full
length
fl
smn
mrna
protein
product
research
novarti
institut
biomed
research
util
phenotyp
assay
screen
smallmolecul
abil
reduc
exclus
exon
increas
flsmn
protein
level
two
report
gene
fulllength
design
within
motor
neuron
cell
line
indic
either
exon
inclus
exclus
respect
figur
compound
novarti
compound
librari
compound
screen
two
report
gene
gave
complementari
result
report
simultan
increas
flsmn
decreas
report
hit
lead
identif
figur
gene
express
analysi
rnaseq
reveal
compound
regul
discret
set
splice
variant
indic
fairli
select
splice
modul
furthermor
demonstr
promis
vivo
activ
structur
close
resembl
inact
figur
tocsi
nmr
surfac
plasmon
reson
confirm
bind
directli
snrnp
splice
site
comput
model
use
suggest
bind
mode
compound
snrnpsmn
premrna
figur
taken
togeth
result
suggest
model
function
bind
near
nga
site
stabil
snrnpsmn
exon
complex
therefor
enabl
exon
inclus
also
note
work
first
exampl
splice
inhibitor
earlier
exampl
team
ptc
therapeut
hoffmannla
roch
discov
seri
compound
display
excel
vivo
activ
modul
splice
potenti
treatment
sma
naryshkin
et
al
molecul
display
remark
high
specif
measur
rna
sequenc
oral
bioavail
mous
model
sma
specul
molecul
interact
specif
rna
structur
rnaprotein
complex
within
premrna
though
specif
bind
target
molecul
yet
identifi
anoth
exampl
research
merck
research
laboratori
use
phenotyp
assay
discov
riboswitchbind
small
molecul
howe
et
al
concept
target
riboswitch
longstand
goal
sinc
initi
discoveri
winkler
et
al
approach
focus
redesign
cognat
ligand
develop
improv
inhibitor
describ
work
small
molecul
deem
ribocil
report
inhibitor
fmn
riboswitch
structur
metaboliterespons
element
promot
region
ribb
gene
due
role
riboflavin
biosynthesi
fmn
riboswitch
essenti
bacteri
growth
therefor
attract
target
antibacteri
activ
previous
demonstr
blount
et
al
delet
strain
miss
two
gene
play
role
earlier
step
riboflavin
biosynthesi
riba
ribb
shown
signific
reduct
bacteri
burden
compar
wildtyp
control
intern
librari
small
molecul
screen
phenotyp
assay
identifi
lead
compound
exhibit
antibacteri
effect
produc
clear
zone
growth
inhibit
figur
one
hit
compound
racem
ribocil
caus
reduct
bacteri
burden
also
reduct
level
fad
fmn
effect
also
observ
delet
strain
investig
show
one
enantiom
ribocil
ribocil
b
activ
wherea
ribocil
inact
specif
target
interact
determin
identifi
ribocilresist
mutant
contain
mutat
fmn
riboswitch
within
ribb
gene
point
structur
rna
small
molecul
target
ribocil
display
select
microbiolog
activ
e
coli
possess
either
nativ
fmn
riboswitch
ortholog
fmn
aptam
suppress
addit
exogen
riboflavin
inact
yeast
human
cell
lack
cognat
target
f
nucleatum
fmn
aptam
cocryst
ribocil
order
identifi
key
interact
riboswitch
ligand
figur
remark
ribocil
appear
make
mani
interact
riboswitch
cognat
ligand
despit
appar
structur
similar
fmn
k
nm
discoveri
ribocil
robust
demonstr
phenotyp
screen
excel
way
identifi
druglik
chemic
structur
bind
rna
summari
increas
understand
rna
structur
function
like
lead
broad
varieti
potenti
therapeut
target
small
molecul
continu
develop
technolog
druggabl
assess
inhibitor
discoveri
new
rna
target
invalu
exampl
target
riboswitch
evolv
bind
small
molecul
metabolit
like
differ
challeng
target
lncrna
function
sequest
protein
proteinrna
interact
fact
probabl
like
protein
differ
rna
variabl
difficulti
target
small
molecul
ligand
regardless
biolog
pharmacolog
signific
earli
result
suggest
possibl
design
identifi
small
molecul
modul
function
least
rna
mani
challeng
remain
question
rna
druggabl
far
settl
applic
fragmentbas
approach
may
use
hit
rate
fragmentbas
screen
use
assess
druggabl
protein
target
zhou
huang
anoth
challeng
overcom
problem
specif
select
remain
major
barrier
rnabind
molecul
exampl
current
gener
way
probe
transcriptomewid
bind
small
molecul
advanc
would
transform
howev
implement
structurebas
highthroughput
screen
method
describ
proven
lucr
identifi
new
biolog
activ
small
molecul
scaffold
bind
rna
high
affin
specif
mani
recent
develop
small
molecul
structur
distinct
histor
rnabind
scaffold
display
good
physicochem
properti
proven
activ
cellbas
anim
model
diseas
support
role
rna
therapeut
target
continu
success
technolog
provid
new
open
opportun
develop
innov
therapeut
target
rna
upcom
year
databas
rna
motifsmal
molecul
interact
use
predict
compound
bind
nucleotid
gg
intern
loop
present
associ
r
ggggcc
exp
top
blue
nucleotid
uu
intern
loop
present
dicer
drosha
process
site
cancer
associ
hairpin
precursor
bottom
red
structur
valid
lead
compound
bind
r
ggggcc
hairpin
precursor
shown
blue
red
respect
haga
et
al
velagapudi
et
al
chemic
structur
four
tpp
riboswitch
bind
fragment
left
cocryst
structur
tpp
riboswitch
bound
depict
rearrang
right
cressina
et
al
warner
et
al
b
fnmr
fragmentbas
screen
strategi
identifi
chemic
divers
compound
bind
terra
left
fnmr
signal
perturb
broaden
compound
bind
chemic
structur
four
repres
hit
bind
bind
terra
right
fluorin
indic
red
garavi
et
al
c
fragmentbas
screen
hit
dpq
improv
analog
bind
influenza
